High Alcohol Drug Formulations Face Strict Scrutiny as Government Tightens Regulations to Curb Misuse

High Alcohol Drug Formulations Face Strict Scrutiny as Government Tightens Regulations to Curb Misuse​

The Ministry of Health and Family Welfare has issued significant amendments to the Drugs Rules, 1945, marking a major step in strengthening oversight over medicinal products containing high concentrations of ethyl alcohol. The regulatory shift aims specifically at preventing the diversion and misuse of certain high-alcohol drug formulations across India.

Previously, many specialized medicinal preparations, such as tinctures of cardamom and ginger, were exempted from licensing requirements under Schedule K. Some of these formulations contained dangerously high levels of ethyl alcohol, reportedly reaching concentrations of 80 to 90% v/v. This susceptibility to misuse prompted state governments to raise concerns regarding the unchecked availability of these powerful substances.

Mandating Licenses for High-Concentration Formulations​

To address these heightened public health risks, the Government has introduced a specific mandate targeting formulations exceeding certain concentration and volume levels. Any medicinal product containing more than 12% v/v ethyl alcohol in quantities surpassing 30 mL is no longer covered under the prior Schedule K exemption.

This decisive change ensures that these potent products must now obtain the requisite licenses under the Drugs and Cosmetics Act, 1940. The regulation aims to channel these items exclusively through the formal and regulated pharmaceutical supply chain, thereby increasing accountability at every stage of distribution.

Shift to Stricter Prescription and Record-Keeping (Schedule H1)​

Beyond requiring licensing, the amendment mandates a fundamental shift in how these products are sold and dispensed. These affected formulations have been transitioned from their exempted status into Schedule H1 of the Drugs Rules, 1945.

The designation under Schedule H1 immediately subjects them to stricter governmental controls. This mandate requires that such drugs must be sold only against the prescription of a Registered Medical Practitioner (RMP). Furthermore, the transition necessitates enhanced record-keeping protocols by dispensing pharmacies.

Strengthening Regulatory Framework for Public Health​

This proactive regulatory intervention is part of the broader government commitment to promoting responsible use of all medicinal products. By removing the previous blanket exemption, the amendment significantly reduces the possibility that these concentrated alcoholic preparations can be used illicitly for intoxication purposes.

The new structure ensures comprehensive regulatory oversight over medicines with high alcohol content. The introduction of licensing and prescription requirements serves as a critical measure to safeguard public health while maintaining the necessary availability of these therapeutic products when legitimately needed.